XTRA:RDCConsumer Retailing
Redcare Pharmacy (XTRA:RDC) Valuation After Strong 2025 Sales Update Attracts Fresh Investor Attention
Redcare Pharmacy stock after 2025 sales update
Redcare Pharmacy (XTRA:RDC) has drawn fresh attention after reporting group sales of €794 million for the fourth quarter of 2025 and full year sales of €2.9b, compared with €675 million and €2.4b a year earlier.
See our latest analysis for Redcare Pharmacy.
The sales update comes after a mixed share price performance, with a 30 day share price return of 8.69%. This compares with a 90 day share price return decline of 23.72% and a 1 year total...